Neurocrine Biosciences Inc financial data

Symbol
NBIX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6027 Edgewood Bend Court, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 317 % +14.7%
Quick Ratio 7.46 % +26.4%
Debt-to-equity 37.8 % -7%
Return On Equity 15.7 % +48.8%
Return On Assets 11.4 % +51.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +3.05%
Common Stock, Shares, Outstanding 101M shares +3.06%
Entity Public Float 7.9B USD -2.44%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 101M shares +3.27%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +3.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.24B USD +25.7%
Costs and Expenses 1.66B USD +5.32%
Operating Income (Loss) 579M USD +184%
Nonoperating Income (Expense) -57.2M USD -220%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 522M USD +107%
Income Tax Expense (Benefit) 136M USD +123%
Net Income (Loss) Attributable to Parent 386M USD +102%
Earnings Per Share, Basic 3.87 USD/shares +97.4%
Earnings Per Share, Diluted 3.78 USD/shares +100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 349M USD +18.9%
Accounts Receivable, after Allowance for Credit Loss, Current 481M USD +15.2%
Inventory, Net 45.8M USD +59%
Other Assets, Current 122M USD +12.5%
Assets, Current 1.88B USD +13.7%
Deferred Income Tax Assets, Net 454M USD +18.6%
Property, Plant and Equipment, Net 80M USD +16.3%
Operating Lease, Right-of-Use Asset 257M USD +218%
Intangible Assets, Net (Excluding Goodwill) 34.5M USD -1.15%
Goodwill 6.1M USD +10.9%
Other Assets, Noncurrent 61.6M USD +42.9%
Assets 3.54B USD +24.1%
Employee-related Liabilities, Current 77.1M USD +12.4%
Liabilities, Current 430M USD -37.9%
Accrued Income Taxes, Noncurrent 135M USD
Operating Lease, Liability, Noncurrent 251M USD +193%
Other Liabilities, Noncurrent 121M USD +192%
Liabilities 816M USD -3.55%
Accumulated Other Comprehensive Income (Loss), Net of Tax 14.5M USD
Retained Earnings (Accumulated Deficit) 81.1M USD
Stockholders' Equity Attributable to Parent 2.72B USD +35.8%
Liabilities and Equity 3.54B USD +24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130M USD
Net Cash Provided by (Used in) Financing Activities 69.9M USD +752%
Net Cash Provided by (Used in) Investing Activities -55M USD -30.6%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 101M shares +3.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 145M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 357M USD +18.4%
Deferred Tax Assets, Valuation Allowance 88.9M USD +32.7%
Deferred Tax Assets, Gross 530M USD +30.7%
Operating Lease, Liability 286M USD +176%
Depreciation 5.3M USD +29.3%
Payments to Acquire Property, Plant, and Equipment 11.2M USD +31.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 402M USD +97.8%
Lessee, Operating Lease, Liability, to be Paid 372M USD +195%
Property, Plant and Equipment, Gross 154M USD +23.1%
Operating Lease, Liability, Current 34.8M USD +95.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34.9M USD +105%
Lessee, Operating Lease, Liability, to be Paid, Year One 35.4M USD +91.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 85.9M USD +283%
Lessee, Operating Lease, Liability, to be Paid, Year Three 35.8M USD +128%
Deferred Tax Assets, Operating Loss Carryforwards 36.4M USD +32.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 121M USD +43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 36.6M USD +129%
Operating Lease, Payments 6.1M USD +38.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 900K USD 0%
Interest Expense 4.6M USD -17.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%